Research & Development

The Research Department of The SASSI Institute is dedicated to maximizing the accuracy and utility of our substance use measures and expanding the Institute’s services to better meet practitioners’ needs. We are involved in collaborative relationships with many SASSI users in the process of gathering data for our research. We are also pleased to consult with SASSI users regarding their research.

Contact our Research Department at research@sassi.com if you have questions or need assistance with any research related aspects of our instruments.

Data Sharing 
If you wish to assist The SASSI Institute by using our instruments and sharing your data to help us further develop, update, and validate our instruments, please e-mail research@sassi.com.

Research Updates from the Blog!

Our Newest Publication on Tianeptine is Now Available

October 22, 2026

Most often sold in the United States as a dietary supplement, nootropic, or research chemical, tianeptine has become better known by the troubling nickname “gas station heroin.” At high doses, it can produce opioid-like effects and lead to dependence, severe withdrawal, poisoning, and even death. This article traces how tianeptine entered the U.S. market and how it is promoted resulting in the alarming present day use trends. Attention is given to a large problem: tianeptine… Read more

Our Commitment to Ongoing Research

April 17, 2025

The SASSI Institute is dedicated to enhancing the utility of our screening tools through ongoing research and development. Our efforts focus on improving our screening instruments, understanding substance use trends, and addressing co-occurring disorders. Key Research Areas: Instrument Validation and Updates: The Institute has conducted recent validation studies to ensure the effectiveness of the SASSI in detecting substance use disorders among adults and adolescents. This includes research on identifying individuals who may underreport or deny… Read more

Another Public Health Threat: The Extensive Use of Bromazolam

February 8, 2024

We recently published a commentary in Public Health Open Journal regarding Bromazolam (fake Xanax) use. It is increasingly being found in the illicit drug supply, mixed with other drugs like fentanyl and heroin, among others. Within the commentary, we examine the current state of the science as it pertains to the public health dangers of Bromazolam and its various illicit distribution networks, not only in North America but across the world. We also examine possible… Read more

Xylazine: The Real Deal

September 7, 2023

Xylazine is a significant drug used by veterinarians specializing in the care of large animals such as horses, cattle, and deer as it provides needed pain relief. Despite this usefulness, as often happens with legal drug supplies, illicit uses become commonplace and result in unintended consequences—in this case, devastating ones. In our new peer reviewed article we examine the current state of the science as pertains to xylazine and the various uses of the illicit… Read more

SAMSHA Survey 

June 15, 2023

June is National Pride month so we thought we would bring attention to the just released SAMSHA survey on Lesbian, Gay and Bisexual Results from the 2021 and 2022 National Surveys on Drug Use and Behavioral Health. The results point to the heavy societal stressors of this minority population in regards to mental health and the overall use of substances as a significant coping response.  The behavioral survey looks at any mental illness, serious mental… Read more

How the SASSI can be a Useful Tool in the LGBTQIA+ Community

May 18, 2023

Overall, the SASSI can be a valuable tool for helping members of the LGBTQIA+ community by identifying and addressing substance use disorders. It can provide a standardized and sensitive way to screen for these issues and can help to ensure that individuals receive appropriate care and support based on their unique needs and experiences. Read more